| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 11 | 2020 | 2668 | 2.140 |
Why?
|
| Tumor Microenvironment | 12 | 2020 | 2999 | 1.900 |
Why?
|
| Neoplasm Metastasis | 22 | 2020 | 5328 | 1.490 |
Why?
|
| RNA Splicing | 10 | 2021 | 362 | 1.430 |
Why?
|
| Myeloid-Derived Suppressor Cells | 5 | 2020 | 103 | 1.370 |
Why?
|
| Stem Cell Niche | 3 | 2020 | 94 | 1.360 |
Why?
|
| Breast Neoplasms | 27 | 2020 | 16226 | 1.110 |
Why?
|
| Exons | 10 | 2009 | 1388 | 1.020 |
Why?
|
| Osteogenesis | 2 | 2018 | 264 | 0.990 |
Why?
|
| RNA Splice Sites | 7 | 2009 | 116 | 0.990 |
Why?
|
| Epithelial-Mesenchymal Transition | 6 | 2019 | 1004 | 0.950 |
Why?
|
| Macrophages | 5 | 2020 | 1376 | 0.840 |
Why?
|
| Benzamides | 2 | 2018 | 1882 | 0.810 |
Why?
|
| Neutrophils | 3 | 2020 | 876 | 0.780 |
Why?
|
| Myeloid Cells | 3 | 2019 | 277 | 0.750 |
Why?
|
| Tropism | 1 | 2020 | 19 | 0.740 |
Why?
|
| Methylmalonic Acid | 1 | 2020 | 17 | 0.740 |
Why?
|
| Triple Negative Breast Neoplasms | 6 | 2021 | 1372 | 0.700 |
Why?
|
| Iliac Artery | 2 | 2016 | 100 | 0.670 |
Why?
|
| Pyrazoles | 2 | 2018 | 1543 | 0.650 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 3 | 2009 | 18 | 0.640 |
Why?
|
| Introns | 7 | 2021 | 461 | 0.640 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2020 | 4963 | 0.630 |
Why?
|
| Neoplasms | 8 | 2020 | 15903 | 0.630 |
Why?
|
| Neovascularization, Physiologic | 2 | 2017 | 356 | 0.600 |
Why?
|
| Aurora Kinases | 1 | 2017 | 194 | 0.560 |
Why?
|
| Bone and Bones | 2 | 2017 | 612 | 0.560 |
Why?
|
| RNA Precursors | 4 | 2015 | 125 | 0.550 |
Why?
|
| Transforming Growth Factor beta | 5 | 2015 | 1133 | 0.550 |
Why?
|
| Animals | 48 | 2021 | 62757 | 0.540 |
Why?
|
| Bone Marrow | 4 | 2017 | 2431 | 0.530 |
Why?
|
| Interleukin-17 | 1 | 2015 | 257 | 0.450 |
Why?
|
| Cell Separation | 1 | 2015 | 616 | 0.450 |
Why?
|
| Specimen Handling | 1 | 2015 | 314 | 0.450 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 981 | 0.440 |
Why?
|
| Cell Line, Tumor | 23 | 2021 | 14868 | 0.430 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2013 | 672 | 0.410 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 1574 | 0.410 |
Why?
|
| Signal Transduction | 17 | 2021 | 12219 | 0.400 |
Why?
|
| Mice | 34 | 2021 | 36006 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 1053 | 0.400 |
Why?
|
| Alternative Splicing | 4 | 2008 | 613 | 0.370 |
Why?
|
| Disease Progression | 8 | 2020 | 6905 | 0.360 |
Why?
|
| Humans | 62 | 2021 | 271636 | 0.350 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 1599 | 0.350 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2009 | 99 | 0.330 |
Why?
|
| Mice, Inbred BALB C | 4 | 2018 | 2468 | 0.320 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2016 | 2471 | 0.320 |
Why?
|
| Immunotherapy | 2 | 2019 | 3539 | 0.310 |
Why?
|
| Computational Biology | 2 | 2005 | 1278 | 0.310 |
Why?
|
| Spliceosomes | 2 | 2021 | 75 | 0.300 |
Why?
|
| MCF-7 Cells | 3 | 2020 | 554 | 0.300 |
Why?
|
| Mice, Nude | 8 | 2020 | 4358 | 0.290 |
Why?
|
| Receptors, Estrogen | 2 | 2018 | 2267 | 0.280 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 7463 | 0.280 |
Why?
|
| Vertebrates | 1 | 2006 | 63 | 0.270 |
Why?
|
| Female | 36 | 2021 | 148992 | 0.260 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2018 | 189 | 0.260 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5420 | 0.260 |
Why?
|
| Evolution, Molecular | 2 | 2008 | 869 | 0.260 |
Why?
|
| Estrogen Receptor alpha | 2 | 2020 | 742 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 7222 | 0.250 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 14653 | 0.250 |
Why?
|
| Models, Genetic | 3 | 2017 | 1167 | 0.250 |
Why?
|
| RNA, Messenger | 5 | 2018 | 6488 | 0.240 |
Why?
|
| Codon, Terminator | 1 | 2004 | 43 | 0.230 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2015 | 640 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 9093 | 0.220 |
Why?
|
| Wnt Signaling Pathway | 2 | 2018 | 445 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2020 | 3924 | 0.210 |
Why?
|
| Cell Movement | 4 | 2018 | 2503 | 0.210 |
Why?
|
| Codon, Nonsense | 1 | 2003 | 160 | 0.210 |
Why?
|
| Genome | 1 | 2006 | 690 | 0.210 |
Why?
|
| 5' Untranslated Regions | 2 | 2018 | 99 | 0.210 |
Why?
|
| Artificial Intelligence | 2 | 2005 | 430 | 0.210 |
Why?
|
| Cell Survival | 5 | 2021 | 3075 | 0.210 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2020 | 1372 | 0.200 |
Why?
|
| Brain Neoplasms | 5 | 2021 | 4993 | 0.200 |
Why?
|
| ErbB Receptors | 4 | 2020 | 2383 | 0.200 |
Why?
|
| Statistics as Topic | 2 | 2017 | 458 | 0.190 |
Why?
|
| Chemokine CXCL12 | 2 | 2013 | 135 | 0.190 |
Why?
|
| Aconitate Hydratase | 1 | 2020 | 19 | 0.180 |
Why?
|
| Sirtuin 3 | 1 | 2020 | 36 | 0.180 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5246 | 0.180 |
Why?
|
| DNA Fingerprinting | 1 | 2021 | 181 | 0.180 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 35 | 0.180 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 79 | 0.180 |
Why?
|
| Fibroblasts | 2 | 2019 | 1669 | 0.180 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 7 | 0.170 |
Why?
|
| Tamoxifen | 2 | 2020 | 906 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2020 | 158 | 0.170 |
Why?
|
| Calcium | 3 | 2018 | 1594 | 0.170 |
Why?
|
| Neurofibromin 1 | 1 | 2020 | 84 | 0.170 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2020 | 381 | 0.170 |
Why?
|
| Connexin 43 | 1 | 2018 | 46 | 0.160 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 58 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 334 | 0.160 |
Why?
|
| Gene Expression Regulation | 3 | 2008 | 4193 | 0.160 |
Why?
|
| Granulocytes | 1 | 2019 | 243 | 0.160 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 3416 | 0.160 |
Why?
|
| U937 Cells | 1 | 2018 | 179 | 0.160 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 13 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 355 | 0.160 |
Why?
|
| Neoplasm Transplantation | 4 | 2021 | 1566 | 0.160 |
Why?
|
| 3T3 Cells | 1 | 2018 | 387 | 0.160 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 152 | 0.150 |
Why?
|
| Receptors, Androgen | 2 | 2020 | 909 | 0.150 |
Why?
|
| Cadherins | 3 | 2018 | 676 | 0.150 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 37 | 0.150 |
Why?
|
| Mice, SCID | 6 | 2021 | 1851 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2005 | 504 | 0.150 |
Why?
|
| Receptor, ErbB-2 | 3 | 2018 | 2649 | 0.150 |
Why?
|
| Cell Proliferation | 6 | 2020 | 7292 | 0.150 |
Why?
|
| Crosses, Genetic | 1 | 2017 | 257 | 0.150 |
Why?
|
| RNA Interference | 3 | 2018 | 1397 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2018 | 2085 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 498 | 0.140 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 112 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 295 | 0.140 |
Why?
|
| Calcium Signaling | 1 | 2018 | 285 | 0.140 |
Why?
|
| Pericytes | 1 | 2017 | 91 | 0.140 |
Why?
|
| Capillary Permeability | 1 | 2017 | 116 | 0.140 |
Why?
|
| Hindlimb | 1 | 2016 | 111 | 0.140 |
Why?
|
| Lung Neoplasms | 9 | 2020 | 12008 | 0.140 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2017 | 557 | 0.140 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2017 | 117 | 0.140 |
Why?
|
| Wnt Proteins | 3 | 2013 | 392 | 0.140 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 6781 | 0.130 |
Why?
|
| Everolimus | 1 | 2018 | 438 | 0.130 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 349 | 0.130 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2015 | 17 | 0.130 |
Why?
|
| Injections, Intra-Arterial | 1 | 2015 | 55 | 0.130 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 352 | 0.130 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 192 | 0.130 |
Why?
|
| Th1 Cells | 1 | 2017 | 260 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 207 | 0.130 |
Why?
|
| Tenascin | 2 | 2015 | 56 | 0.130 |
Why?
|
| Transcription Factors | 3 | 2020 | 5504 | 0.130 |
Why?
|
| Transplantation, Heterologous | 3 | 2013 | 1086 | 0.130 |
Why?
|
| Smad Proteins | 2 | 2015 | 82 | 0.130 |
Why?
|
| Morpholines | 1 | 2017 | 296 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 882 | 0.120 |
Why?
|
| Tibia | 1 | 2015 | 127 | 0.120 |
Why?
|
| Femur | 1 | 2015 | 162 | 0.120 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 327 | 0.120 |
Why?
|
| Recombination, Genetic | 1 | 2017 | 668 | 0.120 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 435 | 0.120 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 220 | 0.120 |
Why?
|
| Genomics | 3 | 2021 | 2830 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2020 | 5838 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 1294 | 0.120 |
Why?
|
| Stromal Cells | 2 | 2015 | 835 | 0.120 |
Why?
|
| Pyridones | 1 | 2017 | 361 | 0.120 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 2014 | 3 | 0.120 |
Why?
|
| Fibrinolysin | 1 | 2014 | 24 | 0.120 |
Why?
|
| 14-3-3 Proteins | 1 | 2015 | 143 | 0.120 |
Why?
|
| Base Sequence | 4 | 2021 | 5499 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 1035 | 0.110 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 1146 | 0.110 |
Why?
|
| Tumor Escape | 1 | 2015 | 248 | 0.110 |
Why?
|
| Serpins | 1 | 2014 | 74 | 0.110 |
Why?
|
| Genes, myc | 1 | 2015 | 375 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2021 | 1254 | 0.110 |
Why?
|
| Mitochondria | 1 | 2020 | 1313 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2018 | 2457 | 0.110 |
Why?
|
| Neuropeptides | 1 | 2014 | 167 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 1482 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 341 | 0.110 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 770 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 280 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 531 | 0.110 |
Why?
|
| Endothelial Cells | 2 | 2017 | 1047 | 0.110 |
Why?
|
| Interferon-gamma | 1 | 2017 | 1180 | 0.110 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 3472 | 0.100 |
Why?
|
| Aging | 1 | 2020 | 1578 | 0.100 |
Why?
|
| Glucose | 1 | 2018 | 1242 | 0.100 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1013 | 0.100 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2013 | 249 | 0.100 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 5996 | 0.100 |
Why?
|
| Carcinoma | 2 | 2020 | 2623 | 0.100 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 130 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 4070 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 1014 | 0.090 |
Why?
|
| Prostate | 1 | 2016 | 1138 | 0.090 |
Why?
|
| Models, Biological | 2 | 2017 | 3223 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2013 | 487 | 0.090 |
Why?
|
| Carcinogenesis | 2 | 2014 | 1037 | 0.090 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 754 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 641 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2016 | 2912 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1469 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 13989 | 0.090 |
Why?
|
| Mammary Glands, Animal | 1 | 2013 | 635 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 284 | 0.080 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2009 | 35 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2011 | 294 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 1236 | 0.080 |
Why?
|
| Gene Expression | 1 | 2017 | 3688 | 0.080 |
Why?
|
| Cricetulus | 1 | 2009 | 215 | 0.080 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 211 | 0.080 |
Why?
|
| Genetic Techniques | 2 | 2008 | 155 | 0.080 |
Why?
|
| Sequence Alignment | 2 | 2011 | 883 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 1142 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 3934 | 0.080 |
Why?
|
| Cricetinae | 1 | 2009 | 793 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 1134 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2015 | 10354 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 278 | 0.070 |
Why?
|
| Selection, Genetic | 1 | 2008 | 198 | 0.070 |
Why?
|
| Mutation | 5 | 2020 | 15913 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2007 | 247 | 0.070 |
Why?
|
| Expressed Sequence Tags | 1 | 2006 | 108 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2014 | 1730 | 0.070 |
Why?
|
| Alu Elements | 1 | 2006 | 90 | 0.070 |
Why?
|
| Genetic Code | 1 | 2005 | 50 | 0.070 |
Why?
|
| Prognosis | 4 | 2018 | 22525 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2018 | 910 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 203 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2017 | 1571 | 0.060 |
Why?
|
| Genome, Insect | 1 | 2006 | 104 | 0.060 |
Why?
|
| RNA, Double-Stranded | 2 | 2021 | 96 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 810 | 0.060 |
Why?
|
| Gene Amplification | 2 | 2021 | 770 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2006 | 214 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2007 | 451 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2018 | 4984 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1085 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 946 | 0.060 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2004 | 6 | 0.060 |
Why?
|
| Gene Expression Profiling | 4 | 2015 | 5180 | 0.060 |
Why?
|
| Histones | 1 | 2011 | 1513 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 641 | 0.060 |
Why?
|
| Untranslated Regions | 1 | 2003 | 15 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2015 | 3262 | 0.060 |
Why?
|
| Base Composition | 1 | 2003 | 93 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 845 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 1438 | 0.050 |
Why?
|
| Apoptosis | 4 | 2021 | 7834 | 0.050 |
Why?
|
| Kinetics | 1 | 2006 | 2242 | 0.050 |
Why?
|
| Guanine | 1 | 2003 | 157 | 0.050 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 248 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 5804 | 0.050 |
Why?
|
| Brain | 2 | 2014 | 4251 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 4370 | 0.050 |
Why?
|
| Genes | 1 | 2004 | 613 | 0.050 |
Why?
|
| Cytosine | 1 | 2003 | 157 | 0.050 |
Why?
|
| Transfection | 2 | 2007 | 3165 | 0.050 |
Why?
|
| Mammals | 1 | 2004 | 374 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3670 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 10259 | 0.050 |
Why?
|
| Chromatin | 1 | 2007 | 1049 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 10743 | 0.050 |
Why?
|
| Cell Line | 2 | 2007 | 5431 | 0.050 |
Why?
|
| Receptors, Notch | 2 | 2016 | 377 | 0.050 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 116 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 31032 | 0.050 |
Why?
|
| RNA | 1 | 2005 | 1069 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2003 | 751 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 866 | 0.040 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 8 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2021 | 269 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 150 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 25 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 120 | 0.040 |
Why?
|
| Endocytosis | 1 | 2020 | 239 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 219 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 415 | 0.040 |
Why?
|
| Estrogen Antagonists | 1 | 2020 | 219 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2015 | 1717 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 3512 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 718 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 2018 | 11 | 0.040 |
Why?
|
| Phospholipid Ethers | 1 | 2018 | 14 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 19 | 0.040 |
Why?
|
| Software | 1 | 2005 | 1383 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 314 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 231 | 0.040 |
Why?
|
| Protein Array Analysis | 1 | 2021 | 505 | 0.040 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2018 | 53 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 109 | 0.040 |
Why?
|
| Triterpenes | 1 | 2018 | 68 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 72 | 0.040 |
Why?
|
| Lung | 1 | 2009 | 3293 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 66 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 80 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 2398 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2018 | 103 | 0.040 |
Why?
|
| Pyrimidines | 2 | 2015 | 3663 | 0.040 |
Why?
|
| Ribosomes | 1 | 2018 | 169 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 759 | 0.040 |
Why?
|
| Aged | 2 | 2020 | 73421 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 5102 | 0.040 |
Why?
|
| Estradiol | 1 | 2020 | 881 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 3697 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 184 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2017 | 360 | 0.030 |
Why?
|
| Estrogens | 1 | 2020 | 844 | 0.030 |
Why?
|
| Purines | 1 | 2018 | 275 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 533 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 23 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 44 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 601 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 1965 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2004 | 5779 | 0.030 |
Why?
|
| ras Proteins | 1 | 2020 | 802 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2015 | 102 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2017 | 496 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 115 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 534 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 7971 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 154 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 1076 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 4636 | 0.030 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 1740 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2011 | 1486 | 0.030 |
Why?
|
| Plasminogen Activators | 1 | 2014 | 55 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1468 | 0.030 |
Why?
|
| Phenotype | 1 | 2005 | 6510 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2014 | 154 | 0.030 |
Why?
|
| Proteomics | 1 | 2021 | 1436 | 0.030 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2012 | 26 | 0.030 |
Why?
|
| Retroviridae | 1 | 2013 | 376 | 0.030 |
Why?
|
| Interleukin-11 | 1 | 2012 | 38 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2012 | 157 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 379 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 737 | 0.030 |
Why?
|
| Breast | 1 | 2019 | 1379 | 0.030 |
Why?
|
| Melanoma | 1 | 2009 | 5591 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 745 | 0.030 |
Why?
|
| Goosecoid Protein | 1 | 2011 | 16 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 681 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 600 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 2495 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 771 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 102 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2012 | 229 | 0.020 |
Why?
|
| Quinazolines | 1 | 2015 | 953 | 0.020 |
Why?
|
| Astrocytes | 1 | 2014 | 405 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2011 | 227 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 640 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2015 | 1230 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2020 | 4191 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2009 | 21 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 31 | 0.020 |
Why?
|
| Sialyltransferases | 1 | 2009 | 29 | 0.020 |
Why?
|
| Leukocytes | 1 | 2011 | 426 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 9323 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2016 | 1890 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 543 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 5111 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 1041 | 0.020 |
Why?
|
| Male | 4 | 2020 | 128836 | 0.020 |
Why?
|
| Angiopoietins | 1 | 2008 | 35 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2008 | 56 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 4263 | 0.020 |
Why?
|
| Macaca | 1 | 2008 | 93 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 487 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 249 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 754 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 4998 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2007 | 275 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 1755 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 498 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2006 | 43 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2008 | 213 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 3922 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1940 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 1146 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 2128 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 4635 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 398 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 2624 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 790 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 4884 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12530 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 3070 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 2218 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 1666 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2011 | 2759 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2006 | 908 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 7929 | 0.010 |
Why?
|
| Genome, Human | 1 | 2007 | 1878 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 3363 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 39731 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 33846 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 4888 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 81791 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 90349 | 0.010 |
Why?
|